These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9514196)

  • 1. Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease.
    Andjelkovic AV; Pachter JS
    J Neurosci Res; 1998 Feb; 51(4):423-30. PubMed ID: 9514196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
    Grammas P; Martinez J; Miller B
    Expert Rev Mol Med; 2011 Jun; 13():e19. PubMed ID: 21676288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple sclerosis and endothelial dysfunction (a review)].
    Spirina NN; Spirin NN; Fadeeva OA; Shipova EG; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):32-42. PubMed ID: 24416810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.
    Zipp F; Aktas O
    Trends Neurosci; 2006 Sep; 29(9):518-27. PubMed ID: 16879881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both soluble and membrane-associated TNF activate brain microvascular endothelium: relevance to multiple sclerosis.
    Burger D; Lou J; Dayer JM; Grau GE
    Mol Psychiatry; 1997 Mar; 2(2):113-6. PubMed ID: 9106230
    [No Abstract]   [Full Text] [Related]  

  • 6. Microcirculation of the brain: morphological assessment in degenerative diseases and restoration processes.
    Kolinko Y; Krakorova K; Cendelin J; Tonar Z; Kralickova M
    Rev Neurosci; 2015; 26(1):75-93. PubMed ID: 25337818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood-brain barrier in neuroinflammatory diseases.
    de Vries HE; Kuiper J; de Boer AG; Van Berkel TJ; Breimer DD
    Pharmacol Rev; 1997 Jun; 49(2):143-55. PubMed ID: 9228664
    [No Abstract]   [Full Text] [Related]  

  • 8. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pathogenesis of multiple sclerosis. Basal membrane injury by persisting viral infection].
    Simon J
    Fortschr Med; 1989 Jan; 107(1):53. PubMed ID: 2920985
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?
    Kirk S; Frank JA; Karlik S
    J Neurol Sci; 2004 Feb; 217(2):125-30. PubMed ID: 14706213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis is primarily a neurodegenerative disease.
    Chaudhuri A
    J Neural Transm (Vienna); 2013 Oct; 120(10):1463-6. PubMed ID: 23982272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
    Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins as potential therapeutic agents in neuroinflammatory disorders.
    Stüve O; Youssef S; Steinman L; Zamvil SS
    Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory alterations in the myocardial microcirculation.
    Hansen PR
    J Mol Cell Cardiol; 1998 Dec; 30(12):2555-9. PubMed ID: 9990527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keynote review: epithelial and endothelial barriers in human disease.
    Mullin JM; Agostino N; Rendon-Huerta E; Thornton JJ
    Drug Discov Today; 2005 Mar; 10(6):395-408. PubMed ID: 15808819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis.
    Washington R; Burton J; Todd RF; Newman W; Dragovic L; Dore-Duffy P
    Ann Neurol; 1994 Jan; 35(1):89-97. PubMed ID: 7506877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system.
    't Hart BA; Amor S
    Curr Opin Neurol; 2003 Jun; 16(3):375-83. PubMed ID: 12858076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
    Minagar A; Maghzi AH; McGee JC; Alexander JS
    Neurol Res; 2012 Oct; 34(8):738-45. PubMed ID: 22828184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.